Translating Biomarker Studies from Pre-Clinical to Clinical Development
Time: 3:45 pm
day: Conference Day 2
Details:
- Identifying clinically meaningful biomarkers that impact the design of studies at different development stages
- Interpreting biomarker study results – key considerations
- Patient selection – Are there options other than CDx development?
